Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Filed Mar 30, 2020 · 10-K · 90 days after period end · 0001753926-20-000068
| Metric | Q4 2019 | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $5.34K | — | — | $0.00 |
| Net Income | -$1.55K | -$1.22M | -$1.17M | -$1.24M |
| EPS Diluted | $0.00 | — | — |
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2019 · filed Mar 30, 2020 · 90 d after period end
